*ST Jiyou announced that on August 7, 2026, the company received the “Inquiry Letter on the Draft Report on Major Asset Purchases and Related Transactions of Anhui Jiyou New Materials Co., Ltd.” from the Shanghai Stock Exchange. The company plans to purchase 50.76% of Huiju Pharmaceutical's shares in cash for 1,006 billion yuan, and the controlling shareholder plans to transfer 5.0526% of the listed company's shares. The Shanghai Stock Exchange raised questions about the transaction plan, the underlying company situation, transaction valuation, etc., and requested the company to respond in writing and revise the draft within ten trading days. The company will promptly respond and fulfill disclosure obligations as required.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.